Clinical Trial

Hematological Markers in Idiopathic Carpal Tunnel Syndrome

Completed
View on ClinicalTrials.gov →
Summary
Carpal Tunnel Syndrome (CTS) cases are still classified as idiopathic. The rationale of this research is to investigate the role of chronic inflammation and vitamin B12 deficiency in the onset and severity of idiopathic CTS. This case-control study aims to evaluate inflammatory hematological markers and vitamin B12 levels in patients with idiopathic CTS compared to healthy controls, and to analyze their correlation with clinical and electrophysiological severity of the disease
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-29; most recent amendment 2026-03-23.
Status change: Enrolling by Invitation → Completed 2026-01-31
Trial Details
NCT Number NCT06952647
Lead Sponsor Ankara Training and Research Hospital
Conditions Carpal Tunnel Syndrome (CTS), Biomarkers / Blood
Enrollment 197 participants
Start Date 2025-04-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11